The Value for Investment in New Therapies

Panelists:
Todd Brady, MD, PhD, President & CEO - Aldeyra
Doug Faunce, PhD, Executive Director, Head of Search and Evaluation for Eye Care - AbbVie Ventures
Céline Olmiere, PhD, Head - Théa Open Innovation
Mike Rosco, MD, Regional Medical Director - Harrow

Moderated By:
Stewart Sylvester, Chief Sales Officer - Ora

Website:

FOLLOW Ophthalmology Innovation Source On Social Media:

JOIN Our Group For Ophthalmology Innovation & Investment On LinkedIn

SUBSCRIBE To Our Weekly OIS Newsletter

VIEW Our Past Ophthalmology Event Conferences:

REGISTER For Our Next Meeting:

#OIS #Ophthalmology #Healthcare #Ophthalmic #Medicalinnovation #Retina #Eyediseases

_________________________________________________________________

About OIS

Ophthalmology Innovation Summit (OIS) facilitates meaningful interactions and the exchange of information between clinical, capital, and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

Since 2009, the Ophthalmology Innovation Summit programs are independently produced conferences presented annually by Healthegy, Inc.